Cargando…

The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

Despite new treatment modalities, the clinical outcome in a substantial number of patients with multiple myeloma (MM) has yet to be improved. Antibody-based targeted therapies for myeloma patients could make use of the HM1.24 antigen (CD317), a surface molecule overexpressed on malignant plasma cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staudinger, M, Glorius, P, Burger, R, Kellner, C, Klausz, K, Günther, A, Repp, R, Klapper, W, Gramatzki, M, Peipp, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080209/ https://www.ncbi.nlm.nih.gov/pubmed/24927408 http://dx.doi.org/10.1038/bcj.2014.38

Ejemplares similares

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
por: Peipp, Matthias, et al.
Publicado: (2015)

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
por: Klausz, Katja, et al.
Publicado: (2017)

Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
por: Harada, Takeshi, et al.
Publicado: (2014)

Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed against the AML Stem Cell Antigen CD96
por: Mohseni Nodehi, Sahar, et al.
Publicado: (2012)

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
por: Klausz, Katja, et al.
Publicado: (2020)

Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
por: Burger, Renate, et al.
Publicado: (2021)

Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype
por: Kellner, Christian, et al.
Publicado: (2013)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain
por: Fujimoto, Keiko, et al.
Publicado: (2020)

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia
por: Kellner, Christian, et al.
Publicado: (2018)

An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
por: Dinota, A., et al.
Publicado: (1989)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients
por: Bera, T K, et al.
Publicado: (2018)

Proton-antiproton annihilation into $\eta\eta\pi$ : observation of a scalar resonance decaying into $\eta\eta$
por: Amsler, Claude, et al.
Publicado: (1992)

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
por: Lutz, Sebastian, et al.
Publicado: (2023)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Tribody [(HER2)(2)xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
por: Oberg, Hans H., et al.
Publicado: (2018)

Strategies for purging CD96(+) stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemia
por: Staudinger, Matthias, et al.
Publicado: (2013)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display
por: Krohn, Steffen, et al.
Publicado: (2022)

A study of the $\eta \eta'$ and $\eta' \eta'$ channels produced in central pp interactions at 450 GeV/c
por: Barberis, D, et al.
Publicado: (2000)

Phenomenological evidence for the gluon content of $\eta$ and $\eta$'
por: Ball, P, et al.
Publicado: (1995)

The case history of 'Sir H.M.'.
por: Longfield-Jones, G M
Publicado: (1988)

Evidence for the box anomaly in $\eta$ and $\eta$' decays
por: Feindt, Michael, et al.
Publicado: (1992)

A study of the $\eta \eta{'}$ and $\eta{'}\eta{'}$ channels produced in central p p interactions at 450 GeV/c
por: Barberis, D, et al.
Publicado: (2000)

$\eta-\eta'$ mixing and chiral anomalies in $\eta/\eta' \to \pi^+ \pi^- \gamma$ decays
por: Kiselev, A, et al.
Publicado: (1994)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
por: Baumann, Niklas, et al.
Publicado: (2022)

Measurement of the production rates of $\eta$ and $\eta$' in hadronic Z decays
por: Buskulic, Damir, et al.
Publicado: (1992)

Search for the decays $\eta$ --> $\mu$e and $\eta$ --> e+e-
por: White, D B, et al.
Publicado: (1996)

Implications of $\eta$-$\eta$' mixing for the decay $\eta$ --> 3$\pi$
por: Leutwyler, H.
Publicado: (1996)

Study of $\eta$ and $\eta'$ Production in $\overline{n}p$ Annihilations
por: Filippi, A, et al.
Publicado: (1999)

H.M. the Emperor of Ethiopia
por: CERN PhotoLab
Publicado: (1967)

ST-HM: not only cranes
por: Bertone, C
Publicado: (2002)

ST-HM equipment consolidation
por: Rühl, I, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_db78cr1sebs1imdt2smvi88gtt